Rhumbline Advisers Vaxxinity, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
BUY
$0.62 - $0.86 $3,416 - $4,738
5,510 Added 14.09%
44,603 $32,000
Q3 2023

Nov 09, 2023
BUY
$1.25 - $3.0 $3,321 - $7,971
2,657 Added 7.29%
39,093 $53,000
Q2 2023

Aug 08, 2023
BUY
$1.73 - $2.79 $63,034 - $101,656
36,436 New
36,436 $91,000

Others Institutions Holding VAXX

# of Institutions
2
Shares Held
198K
Call Options Held
0
Put Options Held
0
View Full List

About Vaxxinity, Inc.

VAXX Quotes by TradingView
  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email